New drug uses antibodies to stop chronic migraines by blocking the neural pathway that sends pain signals to the brain during a migraine. Phase III trials on about 1,000 subjects are complete now and there are already plans for it to be approved by the FDA. Read full article...
Source: https://www.nbcnews.com/health/health-news/new-drug-uses-antibodies-stop-chronic-migraines-without-side-effects-n866696